Ocrelizumab
(asked on 14th November 2018) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the affordability to the NHS of ocrelizumab for the treatment of progressive multiple sclerosis.
This question was answered on 22nd November 2018
The Department has made no assessment. The National Institute for Health and Care Excellence is currently developing technology appraisal guidance on the use of ocrelizumab for treating primary progressive multiple sclerosis.